Sunshine Biopharma introduces new generic drugs in Canada
Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company currently valued at $5.8 million and showing promising revenue growth of 62% over the last twelve months, announced the release of two ...
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
In addition, Sunshine Biopharma is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and (ii) PLpro protease ...